{{medical}}
{{NoteTA|G1=Chemistry|G2=Medicine}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462079943
| IUPAC_name = (''RS'')-''N,N''-dimethyl-1-(10''H''-phenothiazin-10-yl)propan-2-amine
| image = Promethazine Enantiomers Structural Formulae.png
| width = 125 <!-- image is quite low res, so don't over enlarge -->
| imagename = 1 : 1 mixture (racemate)
| drug_name = 异丙嗪

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|promethazine-hydrochloride}}
| MedlinePlus = a682284
| pregnancy_AU = C
| pregnancy_US = C
| pregnancy_category =  
| legal_AU =  
| legal_UK = P
| legal_US = Rx-only
| legal_status = <br />(injection POM<small>([[United_Kingdom|UK]])</small>)
| routes_of_administration = Oral, [[suppository|rectal]], [[intravenous_therapy|IV]], [[intramuscular_injection|IM]], [[topical|topical]]

<!--Pharmacokinetic data-->
| bioavailability = 88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability<ref name="pmid10965395">{{cite journal | author = Strenkoski-Nix LC, Ermer J, DeCleene S, Cevallos W, Mayer PR | title = Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects | journal = American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists | volume = 57 | issue = 16 | pages = 1499–505 | pmid = 10965395 | doi = | url = http://www.ajhp.org/cgi/pmidlookup?view=long&pmid=10965395|date=August 2000}}</ref>
| protein_bound = 93%
| metabolism = [[Liver|Hepatic]] [[glucuronidation|glucuronidation]] and [[sulfoxide|sulfoxidation]]
| elimination_half-life = 10-19 hours<ref name="pmid10965395" /><ref name="pmid2866055">{{cite journal | author = Paton DM, Webster DR | title = Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines) | journal = Clinical Pharmacokinetics | volume = 10 | issue = 6 | pages = 477–97 | year = 1985 | pmid = 2866055 | doi =  | url = http://content.wkhealth.com/linkback/openurl?issn=0312-5963&volume=10&issue=6&spage=477 }}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
| excretion = [[Kidney|Renal]] and biliary

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 60-87-7
| CAS_supplemental = <br/>58-33-3 (hydrochloride) <!-- Also CAS verified -->
| ATC_prefix = D04
| ATC_suffix = AA10
| ATC_supplemental =  {{ATC|R06|AD02}}, {{ATC|R06|AD05}}
| PubChem = 4926
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = APRD00601
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4759
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = FF28EJQ494
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00494
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8461
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 643

<!--Chemical data-->
| C = 17 | H = 20 | N = 2 | S = 1 
| molecular_weight = 284.42 [[克|g]]/[[摩尔_(单位)|mol]]
| smiles = S2c1ccccc1N(c3c2cccc3)CC(N(C)C)C
| InChI = 1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
| InChIKey = PWWVAXIEGOYWEE-UHFFFAOYAG
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PWWVAXIEGOYWEE-UHFFFAOYSA-N
}}
'''鹽酸異丙嗪'''（{{lang-en|Promethazine}}，又名'''盐酸普鲁米近'''(''Promethazine Hydrochloride'')或'''非那根'''(''Phenergan'')）是一種常見的止咳藥物，為第一代[[抗組織胺藥|抗組織胺藥]]，能竞争性阻断组胺H1受体，对抗组胺所致之毛细血管扩张，並降低其通透性。因此，能夠平復因為氣管受刺激而引起的咳嗽。

有糖漿溶液及片狀兩種，以糖漿溶液較相見，呈鉻黃色，藥性與[[可待因|可待因]]相似，忌光，可令服用者口乾及產生睡意。這種藥水在其他國家一般都很容易可以在藥房無需處方購買。不過，由於在[[美國|美國]]─特別是[[德薩斯州|德薩斯州]]的[[休斯頓|休斯頓]]─經常被當地的年青人濫用，所以在美國需要醫生處方才可以購買。

2006年4月25日，美國食品藥物管理局發布有關鹽酸異丙嗪藥品安全警示，警告醫生和家長含有鹽酸異丙嗪藥物不宜給不滿兩歲孩子，給超過兩歲較年長的小孩，給予這些藥物應該小心。美國食品藥物管理局在這個安全警示說，已被證實關聯到鹽酸異丙嗪，而發生嚴重呼吸困難的22份報告中有7例死亡，所有兒童年齡均小於兩歲。這種藥物，最初於1951年批准，通常規定為抗組胺藥或過敏藥物。<ref>[http://www.drug-injury.com/druginjurycom/2006/05/phenergan_and_s.html Phenergan And Similar Drugs Associated With Infant Deaths]</ref>3歲以下小孩不應注射鹽酸異丙嗪藥品。

== 參考書目 ==
# Katzung, Bertram G.  "Basic and Clinical Pharmacology", 9th ed (2004). pp. 264–265.

==参考文献==
{{reflist}}
== 外部連結 ==
* [https://web.archive.org/web/20051125100201/http://www.vutoo.com/sina/2005/4-1/15405164836.html 新浪万途健康网：名药名典：西药：盐酸异丙嗪]
* [http://bbs.fh21.com.cn/php2/detail.php?table=drug&id=265 飞华健康网：药物手册：盐酸异丙嗪 (抗组胺药)]{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}
* [http://www.fda.gov/medwatch/SAFETY/2005/phenergan_deardoctorletter.pdf Letter from Wyeth Pharmaceuticals to practitioners regarding use of Phenergan in under twos.] (PDF format)

{{Antihistamines}}
{{Histaminergics}}
{{Hallucinogens}}
{{Hypnotics and sedatives}}

[[Category:止吐劑|Category:止吐劑]]
[[Category:H1受体拮抗剂|Category:H1受体拮抗剂]]
[[Category:催眠药|Category:催眠药]]
[[Category:酚噻嗪|Category:酚噻嗪]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]